Donor CCR5 Δ32 Polymorphism and Outcome Following Cardiac Transplantation
- 17 June 2005
- journal article
- Published by Elsevier in Transplantation Proceedings
- Vol. 37 (5) , 2247-2249
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- The Registry of the International Society for Heart and Lung Transplantation: twenty-first official adult heart transplant report—2004The Journal of Heart and Lung Transplantation, 2004
- AN UPDATE ON CLINICAL OUTCOMES IN HEART AND LUNG TRANSPLANTATIONTransplantation, 2004
- The chemokine receptor, CCR5The International Journal of Biochemistry & Cell Biology, 2004
- BENEFICIAL EFFECTS OF TARGETING CCR5 IN ALLOGRAFT RECIPIENTS1Transplantation, 2001
- Distribution of the CCR5 gene 32-basepair deletion in West Europe. A hypothesis about the possible dispersion of the mutation by the vikings in historical timesHuman Immunology, 2001
- CC chemokine receptor 5 and renal-transplant survivalThe Lancet, 2001
- Cellular and molecular biology of cardiac transplant rejectionJournal of Nuclear Cardiology, 2000
- Chemokines and their receptors in allograft rejectionCurrent Opinion in Immunology, 2000
- The Human CC Chemokine Receptor 5 (CCR5) GeneJournal of Biological Chemistry, 1997
- Inherited Resistance to HIV-1 Conferred by an Inactivating Mutation in CC Chemokine Receptor 5: Studies in Populations with Contrasting Clinical Phenotypes, Defined Racial Background, and Quantified RiskMolecular Medicine, 1997